Data for this review were identified by searches of Medline and Cab Health. Search terms (free text) were “tuberculosis” and “DNA-fingerprinting”. We also looked at articles screened for the purpose of another systematic literature review on the incidence of tuberculosis recurrence; finally we scrutinised the bibliography of the relevant articles retrieved that way. There were no language restrictions. The following inclusion criteria were used: studies published up to July 2002, reporting on
ReviewRecurrence in tuberculosis: relapse or reinfection?
Section snippets
Mechanisms and causes of recurrence
The risk of developing a second episode of tuberculosis after reinfection by Mycobacterium tuberculosis depends first on the risk of reinfection after a first episode (a function of what we have called here “background tuberculosis incidence”) and, second, on the risk of this reinfection breaking down into a second tuberculosis episode. A study2 has shown that HIV-infection, a major risk for an infection (or reinfection) breaking down into a first tuberculosis episode,6 was also a major risk
Methods for the systematic literature review
The methods we used in our search of published articles are given in the Search strategy and selection criteria (see page 286). For comparability reasons, we included only patients in whom the site of disease included the lungs (with or without extrapulmonary involvement) during both initial and recurrent episodes. We extracted frequency measures, data on methods used (study design, case definitions), and risk factors for relapse (treatment regimen, drug-resistance patterns). We classified data
Results
The search through electronic databases returned 391 hits. Most of them were epidemiological studies reporting on previously untreated patients or laboratory studies; eight met our inclusion criteria. Screening 188 articles reviewed for the study on the incidence of recurrence, and the bibliography of all articles meeting our inclusion criteria, allowed retrieval of five more studies. We did not exclude any study on the basis of a small sample size. The main characteristics and findings of the
Discussion
We are confident that our review did not miss any major study recorded in the databases searched, but these databases are notoriously biased towards articles published in the English language. We retrieved only few studies that attempted to quantify the contribution of reinfection to the problem of recurrence of tuberculosis. Fewer still were designed for that particular research objective and/or report on a number of observations such that the study results truly contribute to this research
Conclusions
Only one study in our review2 has reliably compared the incidence rates of recurrence due to reinfection and relapses with a methodology that allows conclusions to be drawn on the increased risk for reinfection (not relapse) among HIV-positive patients in an environment with extremely high-background-tuberculosis incidence.
As our present knowledge basically stems from one study, it would make sense to replicate it, particularly in high-tuberculosis-incidence countries, and among HIV-positive
Search strategy and selection criteria
References (35)
- et al.
Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: a multinational, randomized, comparative study versus Rifampicin. Rifabutin Study Group
Tuber Lung Dis
(1994) - et al.
HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers
Lancet
(2001) - et al.
Tuberculosis vaccine development: recent progress
Trends Microbiol
(2001) - et al.
Relapses in pulmonary tuberculosis
Dis Chest
(1967) - et al.
Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya
Lancet
(1993) - et al.
Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy
Tuber Lung Dis
(1993) - et al.
Recurrence of HIV-related tuberculosis in an endemic area may be due to relapse or reinfection
Tuber Lung Dis
(1994) - et al.
IS6100 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, south India
Tuber Lung Dis
(1995) - et al.
Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium
Lancet
(1999) - et al.
HIV-1 and tuberculosis infection (authors' reply)
Lancet
(2002)
Quality control in tuberculosis bacteriology. 2. The origin of isolated positive cultures from the sputum of patients in four studies of short course chemotherapy in Africa
Tubercle
Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial
Lancet
Interpretation of cluster studies of tuberculosis
Lancet
The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection
Epidemiol Infect
DNA immunization in a mouse model of latent tuberculosis: effect of DNA vaccination on reactivation of disease and on reinfection with a secondary challenge
Infect Immun
Epidemiologic basis of tuberculosis control
Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946–1986, with relevant subsequent publications
Int J Tuberc Lung Dis
Cited by (182)
Type 2 diabetes mellitus and recurrent Tuberculosis: A retrospective cohort in Peruvian military workers
2024, Journal of Clinical Tuberculosis and Other Mycobacterial DiseasesA tuberculosis epidemic model as a proxy for the assessment of the novel M72/AS01<inf>E</inf> vaccine
2023, Communications in Nonlinear Science and Numerical SimulationTuberculosis reinfection and relapse in eastern China: a prospective study using whole-genome sequencing
2022, Clinical Microbiology and InfectionCitation Excerpt :In prior studies, the rate of recurrence is highly variable and has been estimated to range from 4.9% to 47%. Inadequate treatment [8,9], HIV infection [10,11], diabetes [12], bacterial strain [13], and residual radiological lesions [14] have been associated with recurrence. Drug-resistant tuberculosis has also been associated with adverse treatment outcomes increasing rates of recurrence [15].
Immunologic and imaging signatures in post tuberculosis lung disease
2022, Tuberculosis